Back to News
Market Impact: 0.65

Noble Capital reiterates outperform rating on Credo Technology stock

CRDOSFMFG
Analyst EstimatesAnalyst InsightsCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookTechnology & InnovationInvestor Sentiment & Positioning
Noble Capital reiterates outperform rating on Credo Technology stock

Noble Capital reaffirmed its Outperform rating for Credo Technology (CRDO) with a $14 price target, citing a "compelling valuation" relative to peers and a favorable risk/reward profile. This positive outlook is supported by Credo's impressive revenue growth (126.34% YoY) and strong gross profit margins (64.77%), with the stock trading at a lower enterprise value to revenue multiple compared to its industry. Recent positive analyst revisions from Stifel, Needham, and Mizuho, driven by a significant 25.9% quarter-over-quarter revenue increase and strong forward guidance, further reinforce confidence in Credo's growth prospects.

Analysis

Noble Capital has reaffirmed its Outperform rating for Credo Technology Group Holding Ltd. (CRDO), maintaining a $14.00 price target, citing a "compelling valuation." This assessment is based on CRDO's shares trading at 1.2 times enterprise value relative to its 2026 revenue forecast, with Noble Capital targeting a 2.4 times multiple, aiming to bridge the gap with the industry peer average of 2.6 times. Credo Technology has demonstrated substantial financial momentum, evidenced by a 126.34% increase in revenue over the last twelve months and strong gross profit margins of 64.77%. Recent quarterly results further underscore this growth, with a 25.9% quarter-over-quarter revenue surge (6.3% above estimates) and non-GAAP earnings per share of $0.35. The company's forward guidance remains robust, projecting a revenue midpoint of $190 million for the upcoming quarter (representing 11.7% Q/Q growth and 17.6% above prior estimates) and a fiscal year 2026 revenue outlook exceeding $800 million, an 85% year-over-year increase. This positive outlook is broadly shared by other financial analysts; Stifel increased its price target to $80, Needham to $85, and Mizuho to $81, all maintaining Buy or Outperform ratings. These upward revisions are attributed to Credo's strong performance, strategic execution, customer diversification, and ongoing innovation. The stock's significant 148.71% return over the past year reflects existing strong investor confidence.